Malaria infections do not compromise vaccine-induced immunity against tuberculosis in mice

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Parra, Marcela ^a   Derrick, Steven C ^a   Yang, Amy ^a   Tian, JinHua ^a   Kolibab, Kristopher ^a   Oakley, Miranda ^a   Perera, Liyanage P ^b   Jacobs, William R ^c   Kumar, Sanjai ^a   Morris, Sheldon L ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL IMMUNITY; CELL ACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE; IMMUNIZATION; LUNG TUBERCULOSIS; MALARIA; MIXED INFECTION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PARASITE CLEARANCE; PLASMODIUM YOELII; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE; TREATMENT RESPONSE; ANIMAL; C57BL MOUSE; IMMUNOLOGY; PARASITOLOGY; PATHOGENICITY;

ANIMALS; BCG VACCINE; FEMALE; MALARIA; MICE; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; PLASMODIUM YOELII; TUBERCULOSIS, PULMONARY;

EID: 83655212327     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028164     Document Type: Article

References (46)

1. World Health Organization (2010) Global tuberculosis control: WHO report 2010 Geneva, Switzerland WHO Press.
2. World Health Organization (2009) World malaria report 2009 Geneva, Switzerland WHO Press.
3. Thapa R, Mallick D, Biswas B, (2010) Perinatal malaria and tuberculosis co-infection: a case report. Int J Infect Dis 14: e254-256.
4. Range N, Magnussen P, Mugomela A, Malenganisho W, Changalucha J, et al. (2007) HIV and parasitic co-infections in tuberculosis patients: a cross-sectional study in Mwanza, Tanzania. Ann Trop Med Parasitol 101: 343-351.
5. Williamson WA, Greenwood BM, (1978) Impairment of the immune response to vaccination after acute malaria. Lancet 1: 1328-1329.
6. Bradley-Moore AM, Greenwood BM, Bradley AK, Bartlett A, Bidwell DE, et al. (1985) Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination. Ann Trop Med Parasitol 79: 563-573.
7. Srour EF, Segre M, Segre D, (1988) Impairment of T-helper function by a Plasmodium berghei-derived immunosuppressive factor. J Protozool 35: 441-446.
8. Pouniotis DS, Proudfoot O, Bogdanoska V, Scalzo K, Kovacevic S, et al. (2005) Selectively impaired CD8+ but not CD4+ T cell cycle arrest during priming as a consequence of dendritic cell interaction with plasmodium-infected red cells. J Immunol 175: 3525-3533.
9. Ocana-Morgner C, Wong KA, Lega F, Dotor J, Borras-Cuesta F, et al. (2007) Role of TGF-beta and PGE2 in T cell responses during Plasmodium yoelii infection. Eur J Immunol 37: 1562-1574.
10. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, et al. (1994) Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271: 698-702.
11. Colditz GA, Berkey CS, Mosteller F, Brewer TF, Wilson ME, et al. (1995) The efficacy of bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics 96: 29-35.
12. Hesseling AC, Rabie H, Marais BJ, Manders M, Lips M, et al. (2006) Bacille Calmette-Guerin vaccine-induced disease in HIV-infected and HIV-uninfected children. Clin Infect Dis 42: 548-558.
13. von Reyn CF, (2006) Routine childhood Bacille Calmette Guerin immunization and HIV infection. Clin Infect Dis 42: 559-561.
14. Azzopardi P, Bennett CM, Graham SM, Duke T, (2009) Bacille Calmette-Guerin vaccine-related disease in HIV-infected children: a systematic review. Int J Tuberc Lung Dis 13: 1331-1344.
15. Lambert PH, Hawkridge T, Hanekom WA, (2009) New vaccines against tuberculosis. Clin Chest Med 30: 811-826.
16. Parida SK, Kaufmann SH, (2010) Novel tuberculosis vaccines on the horizon. Curr Opin Immunol 22: 374-384.
17. Beresford B, Sadoff JC, (2010) Update on research and development pipeline: tuberculosis vaccines. Clin Infect Dis 50 (Suppl 3): S178-183.
18. Elias D, Akuffo H, Pawlowski A, Haile M, Schon T, et al. (2005) Schistosoma mansoni infection reduces the protective efficacy of BCG vaccination against virulent Mycobacterium tuberculosis. Vaccine 23: 1326-1334.
19. Elias D, Britton S, Aseffa A, Engers H, Akuffo H, (2008) Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine 26: 3897-3902.
20. Mansoor N, Scriba TJ, de Kock M, Tameris M, Abel B, et al. (2009) HIV-1 infection in infants severely impairs the immune response induced by Bacille Calmette-Guerin vaccine. J Infect Dis 199: 982-990.
21. Perera PY, Derrick SC, Kolibab K, Momoi F, Yamamoto M, et al. (2009) A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice. Vaccine 27: 2121-2127.
22. Bardarov S, Bardarov S Jr, Jr, Pavelka MS Jr, Jr, Sambandamurthy V, Larsen M, et al. (2002) Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148: 3007-3017.
23. Smrkovski LL, Strickland GT, (1978) Rodent malaria: BCG-induced protection and immunosuppression. J Immunol 121: 1257-1261.
24. Matsumoto S, Yukitake H, Kanbara H, Yamada H, Kitamura A, et al. (2000) Mycobacterium bovis Bacillus Calmette-Guerin induces protective immunity against infection by Plasmodium yoelii at blood-stage depending on shifting immunity toward Th1 type and inducing protective IgG2a after the parasite infection. Vaccine 19: 779-787.
25. Jeon BY, Derrick SC, Lim J, Kolibab K, Dheenadhayalan V, et al. (2008) Mycobacterium bovis BCG immunization induces protective immunity against nine different Mycobacterium tuberculosis strains in mice. Infect Immun 76: 5173-5180.
26. Derrick SC, Yang AL, Morris SL, (2004) A polyvalent DNA vaccine expressing an ESAT6-Ag85B fusion protein protects mice against a primary infection with Mycobacterium tuberculosis and boosts BCG-induced protective immunity. Vaccine 23: 780-788.
27. Parra M, Yang A, Lim J, Kolibab K, Derrick SC, Cadieux N, et al. (2009) The development of a murine growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis. Clin Vaccine Immunol 16: 1025-1032.
28. Kolibab K, Yang A, Derrick SC, Waldmann TA, Perera LP, et al. (2010) Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant. Clin Vaccine Immunol 17: 793-801.
29. Hinchey J, Jeon BY, Chen B, Alley H, Goldberg M, et al. (2011) Lysine auxotrophy combined with deletion of the SecA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosis. PLoS ONE 6: e15857.
30. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13: 843-850.
31. Lindenstrom T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, et al. (2009) Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells. J Immunol 182: 8047-8055.
32. Derrick SC, Yabe IM, Yang A, Morris SL, (2011) Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells. Vaccine 29: 2902-2909.
33. Brandt L, Feino Cunha J, Weinreich Olsen A, Chilima B, Hirsch P, et al. (2002) Failure of the Mycobacterium bovis BCG vaccine: some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis. Infect Immun 70: 672-678.
34. Buddle BM, Wards BJ, Aldwell FE, Collins DM, de Lisle GW, (2002) Influence of sensitisation to environmental mycobacteria on subsequent vaccination against bovine tuberculosis. Vaccine 20: 1126-1133.
35. Dharmadhikari AS, Nardell EA, (2008) What animal models teach humans about tuberculosis. Am J Respir Cell Mol Biol 39: 503-508.
36. Williamson WA, Greenwood BM, (1978) Impairment of the immune response to vaccination after acute malaria. Lancet 1: 1328-1329.
37. Whittle HC, Brown J, Marsh K, Greenwood BM, Seidelin P, Tighe H, Wedderburn L, (1984) T-cell control of Epstein Barr virus-infected B cells is lost during P. falciparum malaria. Nature 312: 449-450.
38. Perry JA, Oliver CS, Burnett RC, Avery AC, (2005) Cutting edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation. J Immunol 174: 5921-5925.
39. Pouniotis DS, Proudfoot O, Bogdanoska V, Scalzo K, Kovacevic S, Coppel RL, Plebanski M, (2005) Selectively impaired CD8+ but not CD4+ T cell cycle arrest during priming as a consequence of dendritic cell interaction with Plasmodium-infected red cells. J Immunol 175: 3525-3533.
40. Couper KN, Blount DG, Wilson MS, Hafalla JC, Belkaid Y, et al. (2008) IL-10 from CD4+CD25-Foxp3-CD127-adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection. PLoS Pathog 4: e1000004.
41. Schell RF, Ealey WF, Harding GE, Smith DW, (1974) The influence of vaccination on the course of experimental airborne tuberculosis in mice. J Reticuloendothelial Society 16: 131-138.
42. Caruso AM, Serbina N, Klein E, Triebold K, Bloom BR, et al. (1999) Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J Immunol 162: 5407-5416.
43. Derrick SC, Repique C, Snoy P, Yang AL, Morris S, (2004) Immunization with a DNA vaccine cocktail protects mice lacking CD4 cells against an aerogenic infection with Mycobacterium tuberculosis. Infect Immun 72: 1685-1692.
44. Sui Y, Zhu Q, Gagnon S, Dzutsev A, Terabe M, et al. (2010) Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques. Proc Natl Acad Sci U S A 107: 9843-9848.
45. Scott CP, Kumar N, Bishai WR, Manabe YC, (2004) Short report: modulation of Mycobacterium tuberculosis infection by Plasmodium in the murine model. Am J Trop Med Hyg 70: 144-148.
46. Hawkes M, Li X, Crockett M, Diassiti A, Conrad Liles W, et al. (2010) Malaria exacerbates experimental mycobacterial infection in vitro and in vivo. Microbes Infect 12: 864-874.